Skip to main content
Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.140
-0.080 (-6.56%)
At close: Oct 29, 2024, 4:00 PM
1.190
+0.050 (4.39%)
After-hours: Oct 29, 2024, 7:51 PM EDT

Atai Life Sciences Revenue

Atai Life Sciences had revenue of $273.00K in the quarter ending June 30, 2024, with 58.72% growth. This brings the company's revenue in the last twelve months to $378.00K, up 38.97% year-over-year. In the year 2023, Atai Life Sciences had annual revenue of $314.00K with 34.76% growth.

Revenue (ttm)
$378.00K
Revenue Growth
+38.97%
P/S Ratio
n/a
Revenue / Employee
$4,554
Employees
83
Market Cap
191.29M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023314.00K81.00K34.76%
Dec 31, 2022233.00K-20.14M-98.86%
Dec 31, 202120.38M--
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Procaps Group 414.10M
Lifecore Biomedical 128.44M
Organigram Holdings 110.30M
Fulcrum Therapeutics 81.63M
Semler Scientific 61.74M
Zentalis Pharmaceuticals 40.56M
Revenue Rankings

ATAI News

More News